Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
3.970
-0.080 (-1.98%)
At close: Sep 11, 2026, 4:00 PM EDT
3.841
-0.130 (-3.26%)
After-hours: Sep 11, 2026, 7:57 PM EDT
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $6.56 million as of September 11, 2026. Its market cap has decreased by -66.87% in one year.
Market Cap
6.56M
Enterprise Value
3.03M
1-Year Change
-66.87%
Ranking
Category
Stock Price
$3.97
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $6.56M, a decrease of -63.95%. That is a compound annual growth rate of -16.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 6.60M | -51.82% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 7.13M |
| Ernexa Therapeutics | 6.84M |
| AIM ImmunoTech | 6.74M |
| CollPlant Biotechnologies | 6.60M |
| Enveric Biosciences | 6.49M |
| Creative Medical Technology Holdings | 6.33M |
| Purple Biotech | 6.13M |
| Cardio Diagnostics Holdings | 6.07M |